{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:16:02Z","timestamp":1791497762555,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Susac syndrome is a likely autoimmune microangiopathy affecting the brain, retina and inner ear. Due to the rarity of this condition, diagnosis and treatment can be challenging. Diagnosis is based on the presence of the clinical triad of central nervous system dysfunction, branch retinal artery occlusions and sensorineural hearing loss. Typical MRI findings of callosal and peri-callosal lesions may assist in diagnosis. Clinical course can be monophasic, polycyclic or chronic continuous. It is important to look out for red flags to attain an accurate diagnosis and follow a therapeutic algorithm based on severity of the disease and response to treatment. Patients are treated with steroids and immunosuppressive agents with a variable response. Early aggressive treatment especially in severe cases, may help in preventing relapses and morbidity\/disability. This study highlights important diagnostic features and proposes a treatment algorithm based on clinical experience from management of 16 patients from 2 neuroscience centres in the UK since 2007, who were followed up over a long period of 3\u201315\u00a0years.<\/jats:p>","DOI":"10.1007\/s00415-023-11891-z","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:02:47Z","timestamp":1692723767000},"page":"6193-6206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Susac syndrome: neurological update (clinical features, long-term observational follow-up and management of sixteen patients)"],"prefix":"10.1007","volume":"270","author":[{"given":"Smriti","family":"Bose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameep","family":"Karkhanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Mollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0037-454X","authenticated-orcid":false,"given":"Saiju","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"11891_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1212\/wnl.29.3.313","volume":"29","author":"JO Susac","year":"1979","unstructured":"Susac JO, Hardman JM, Selhorst JB (1979) Microangiopathy of the brain and retina. Neurology 29:313\u2013316. https:\/\/doi.org\/10.1212\/wnl.29.3.313","journal-title":"Neurology"},{"key":"11891_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103097","volume":"21","author":"C David","year":"2022","unstructured":"David C, Sacr\u00e9 K, Henri-Feugeas M-C et al (2022) Susac syndrome: a scoping review. Autoimmun Rev 21:103097. https:\/\/doi.org\/10.1016\/j.autrev.2022.103097","journal-title":"Autoimmun Rev"},{"key":"11891_CR3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/jnnp-2016-314295","volume":"87","author":"I Kleffner","year":"2016","unstructured":"Kleffner I, D\u00f6rr J, Ringelstein M et al (2016) Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry 87:1287\u20131295. https:\/\/doi.org\/10.1136\/jnnp-2016-314295","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11891_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrneurol.2013.82","volume":"9","author":"J D\u00f6rr","year":"2013","unstructured":"D\u00f6rr J, Krautwald S, Wildemann B et al (2013) Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol 9:307\u2013316. https:\/\/doi.org\/10.1038\/nrneurol.2013.82","journal-title":"Nat Rev Neurol"},{"key":"11891_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11940-008-0008-y","volume":"10","author":"RM Rennebohm","year":"2008","unstructured":"Rennebohm RM, Egan RA, Susac JO (2008) Treatment of Susac\u2019s syndrome. Curr Treat Options Neurol 10:67\u201374. https:\/\/doi.org\/10.1007\/s11940-008-0008-y","journal-title":"Curr Treat Options Neurol"},{"key":"11891_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/jnnp-2014-308240","volume":"86","author":"TA Hardy","year":"2015","unstructured":"Hardy TA, O\u2019Brien B, Gerbis N et al (2015) Brain histopathology in three cases of Susac\u2019s syndrome: implications for lesion pathogenesis and treatment. J Neurol Neurosurg Psychiatry 86:582\u2013584. https:\/\/doi.org\/10.1136\/jnnp-2014-308240","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11891_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/brain\/awab476","volume":"145","author":"M Marrodan","year":"2022","unstructured":"Marrodan M, Fiol MP, Correale J (2022) Susac syndrome: challenges in the diagnosis and treatment. Brain 145:858\u2013871. https:\/\/doi.org\/10.1093\/brain\/awab476","journal-title":"Brain"},{"key":"11891_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00496-7","author":"H Wiendl","year":"2021","unstructured":"Wiendl H, Gross CC, Bauer J et al (2021) Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/s41582-021-00496-7","journal-title":"Nat Rev Neurol"},{"key":"11891_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1177\/1747493017751737","volume":"15","author":"RM Rennebohm","year":"2020","unstructured":"Rennebohm RM, Asdaghi N, Srivastava S, Gertner E (2020) Guidelines for treatment of Susac syndrome\u2014an update. Int J Stroke 15:484\u2013494. https:\/\/doi.org\/10.1177\/1747493017751737","journal-title":"Int J Stroke"},{"key":"11891_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/01913123.2019.1692117","volume":"43","author":"DP Agamanolis","year":"2019","unstructured":"Agamanolis DP, Prayson RA, Asdaghi N et al (2019) Brain microvascular pathology in Susac syndrome: an electron microscopic study of five cases. Ultrastruct Pathol 43:229\u2013236. https:\/\/doi.org\/10.1080\/01913123.2019.1692117","journal-title":"Ultrastruct Pathol"},{"key":"11891_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jnen\/nlz031","volume":"78","author":"DP Agamanolis","year":"2019","unstructured":"Agamanolis DP, Klonk C, Bigley K, Rennebohm RM (2019) neuropathological findings in Susac syndrome: an autopsy report. J Neuropathol Exp Neurol 78:515\u2013519. https:\/\/doi.org\/10.1093\/jnen\/nlz031","journal-title":"J Neuropathol Exp Neurol"},{"key":"11891_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00005792-199801000-00003","volume":"77","author":"GW Petty","year":"1998","unstructured":"Petty GW, Engel AG, Younge BR et al (1998) Retinocochleocerebral vasculopathy. Medicine (Baltimore) 77:12\u201340. https:\/\/doi.org\/10.1097\/00005792-199801000-00003","journal-title":"Medicine (Baltimore)"},{"key":"11891_CR13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/wnl.35.8.1113","volume":"35","author":"ML Monteiro","year":"1985","unstructured":"Monteiro ML, Swanson RA, Coppeto JR et al (1985) A microangiopathic syndrome of encephalopathy, hearing loss, and retinal arteriolar occlusions. Neurology 35:1113\u20131121. https:\/\/doi.org\/10.1212\/wnl.35.8.1113","journal-title":"Neurology"},{"key":"11891_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12883-020-01892-0","volume":"20","author":"A Wilf-Yarkoni","year":"2020","unstructured":"Wilf-Yarkoni A, Elkayam O, Aizenstein O et al (2020) Increased incidence of Susac syndrome: a case series study. BMC Neurol 20:332. https:\/\/doi.org\/10.1186\/s12883-020-01892-0","journal-title":"BMC Neurol"},{"key":"11891_CR15","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/ene.15317","volume":"29","author":"JD Triplett","year":"2022","unstructured":"Triplett JD, Qiu J, O\u2019Brien B et al (2022) Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome. Eur J Neurol 29:1771\u20131781. https:\/\/doi.org\/10.1111\/ene.15317","journal-title":"Eur J Neurol"},{"key":"11891_CR16","first-page":"351","volume":"25","author":"JO Susac","year":"2004","unstructured":"Susac JO (2004) Susac\u2019s syndrome. Am J Neuroradiol 25:351\u2013352","journal-title":"Am J Neuroradiol"},{"key":"11891_CR17","doi-asserted-by":"publisher","unstructured":"Susac JO, Egan RA, Rennebohm RM, Lubow M (2007) Susac\u2019s syndrome: 1975\u20132005 microangiopathy\/autoimmune endotheliopathy. J Neurol Sci 257(1\u20132):270-272. https:\/\/doi.org\/10.1016\/j.jns.2007.01.036","DOI":"10.1016\/j.jns.2007.01.036"},{"key":"11891_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13256-016-0917-4","volume":"10","author":"E Gertner","year":"2016","unstructured":"Gertner E, Rosenbloom MH (2016) Susac syndrome with prominent dermatological findings and a prompt response to intravenous immunoglobulin, steroids, and rituximab: a case report. J Med Case Rep 10:137. https:\/\/doi.org\/10.1186\/s13256-016-0917-4","journal-title":"J Med Case Rep"},{"key":"11891_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12883-022-02639-9","volume":"22","author":"O Alshaqi","year":"2022","unstructured":"Alshaqi O, Moodie T, Alchaki A (2022) Involuntary crying episodes with Susac\u2019s syndrome\u2014a rare presentation of a rare disease: a case report. BMC Neurol 22:155. https:\/\/doi.org\/10.1186\/s12883-022-02639-9","journal-title":"BMC Neurol"},{"key":"11891_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2012.05.021","volume":"322","author":"I Kleffner","year":"2012","unstructured":"Kleffner I, Duning T, Lohmann H et al (2012) A brief review of Susac syndrome. J Neurol Sci 322:35\u201340. https:\/\/doi.org\/10.1016\/j.jns.2012.05.021","journal-title":"J Neurol Sci"},{"key":"11891_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jns.2010.07.020","volume":"297","author":"A Saux","year":"2010","unstructured":"Saux A, Niango G, Charif M et al (2010) Susac\u2019s syndrome, a rare, potentially severe or lethal neurological disease. J Neurol Sci 297:71\u201373. https:\/\/doi.org\/10.1016\/j.jns.2010.07.020","journal-title":"J Neurol Sci"},{"key":"11891_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/mao.0b013e31818b6ac2","volume":"30","author":"MM Roeser","year":"2009","unstructured":"Roeser MM, Driscoll CLW, Shallop JK et al (2009) Susac syndrome\u2013a report of cochlear implantation and review of otologic manifestations in twenty-three patients. Otol Neurotol 30:34\u201340. https:\/\/doi.org\/10.1097\/mao.0b013e31818b6ac2","journal-title":"Otol Neurotol"},{"issue":"6","key":"11891_CR23","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S0161-6420(98)96005-5","volume":"105","author":"HS Ohalloran","year":"1998","unstructured":"Ohalloran HS, Pearson PA, Lee WB, Susac JO, Berger JR (1998) Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature. Ophthalmology 105(6):1038\u20131044","journal-title":"Ophthalmology"},{"key":"11891_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/s0002-9394(00)00377-9","volume":"129","author":"Y Murata","year":"2000","unstructured":"Murata Y, Inada K, Negi A (2000) Susac syndrome. Am J Ophthalmol 129:682\u2013684. https:\/\/doi.org\/10.1016\/s0002-9394(00)00377-9","journal-title":"Am J Ophthalmol"},{"key":"11891_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jns.2010.08.043","volume":"299","author":"RA Egan","year":"2010","unstructured":"Egan RA, Hills WL, Susac JO (2010) Gass plaques and fluorescein leakage in Susac Syndrome. J Neurol Sci 299:97\u2013100. https:\/\/doi.org\/10.1016\/j.jns.2010.08.043","journal-title":"J Neurol Sci"},{"key":"11891_CR26","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/IAE.0b013e31809ff824","volume":"27","author":"N Martinet","year":"2007","unstructured":"Martinet N, Fardeau C, Adam R et al (2007) Fluorescein and indocyanine green angiographies in Susac syndrome. Retina Phila Pa 27:1238\u20131242. https:\/\/doi.org\/10.1097\/IAE.0b013e31809ff824","journal-title":"Retina Phila Pa"},{"key":"11891_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/01658107.2019.1604764","volume":"43","author":"R Littlewood","year":"2019","unstructured":"Littlewood R, Mollan SP, Pepper IM, Hickman SJ (2019) The utility of fundus fluorescein angiography in neuro-ophthalmology. Neuro-Ophthalmol Aeolus Press 43:217\u2013234. https:\/\/doi.org\/10.1080\/01658107.2019.1604764","journal-title":"Neuro-Ophthalmol Aeolus Press"},{"key":"11891_CR28","doi-asserted-by":"publisher","first-page":"NP41","DOI":"10.1177\/1120672119843281","volume":"30","author":"C Giuffr\u00e8","year":"2020","unstructured":"Giuffr\u00e8 C, Miserocchi E, Marchese A et al (2020) Widefield OCT angiography and ultra-widefield multimodal imaging of Susac syndrome. Eur J Ophthalmol 30:NP41\u2013NP45. https:\/\/doi.org\/10.1177\/1120672119843281","journal-title":"Eur J Ophthalmol"},{"key":"11891_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40942-017-0092-9","volume":"3","author":"AGB Azevedo","year":"2017","unstructured":"Azevedo AGB, Lima LH, M\u00fcller L et al (2017) Anatomical and functional correlation in Susac syndrome: multimodal imaging assessment. Int J Retina Vitr 3:39. https:\/\/doi.org\/10.1186\/s40942-017-0092-9","journal-title":"Int J Retina Vitr"},{"key":"11891_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01464-7","author":"Z Dinah","year":"2021","unstructured":"Dinah Z, Michaella G, Barequet D et al (2021) Susac\u2019s syndrome\u2014a new ocular finding and disease outcome. Eye. https:\/\/doi.org\/10.1038\/s41433-021-01464-7","journal-title":"Eye"},{"key":"11891_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jns.2010.08.032","volume":"299","author":"R Rennebohm","year":"2010","unstructured":"Rennebohm R, Susac JO, Egan RA, Daroff RB (2010) Susac\u2019s Syndrome\u2014update. J Neurol Sci 299:86\u201391. https:\/\/doi.org\/10.1016\/j.jns.2010.08.032","journal-title":"J Neurol Sci"},{"key":"11891_CR32","doi-asserted-by":"publisher","unstructured":"Susac JO, Murtagh FR, Egan RA, et al (2003) MRI findings in Susac\u2019s syndrome. Neurology 61(12):1783\u20131787. https:\/\/doi.org\/10.1212\/01.WNL.0000103880.29693.48","DOI":"10.1212\/01.WNL.0000103880.29693.48"},{"key":"11891_CR33","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/jnnp-2014-309649","volume":"86","author":"N Garg","year":"2015","unstructured":"Garg N, Reddel SW, Miller DH et al (2015) The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases. J Neurol Neurosurg Psychiatry 86:1374\u20131382. https:\/\/doi.org\/10.1136\/jnnp-2014-309649","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11891_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211012349","author":"G Bellanger","year":"2021","unstructured":"Bellanger G, Biotti D, Adam G et al (2021) Leptomeningeal enhancement on post-contrast FLAIR images for early diagnosis of Susac syndrome. Mult Scler J. https:\/\/doi.org\/10.1177\/13524585211012349","journal-title":"Mult Scler J"},{"issue":"1\u20132","key":"11891_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jns.2013.06.017","volume":"333","author":"AM Allmendinger","year":"2013","unstructured":"Allmendinger AM, Viswanadhan N, Klufas RA, Hsu L (2013) Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome. J Neurol Sci 333(1\u20132):25\u201328. https:\/\/doi.org\/10.1016\/j.jns.2013.06.017","journal-title":"J Neurol Sci"},{"key":"11891_CR36","doi-asserted-by":"publisher","unstructured":"Hua LH, Donlon SL, Okuda DT (2014) A case of Susac syndrome with cervical spinal cord involvement on MRI. J Neurol Sci 337(1\u20132):228\u2013231. https:\/\/doi.org\/10.1016\/j.jns.2013.11.040","DOI":"10.1016\/j.jns.2013.11.040"},{"key":"11891_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000994","author":"N Yahyavi-Firouz-Abadi","year":"2021","unstructured":"Yahyavi-Firouz-Abadi N, Kiczek M, Zeiler SR, Wasserman BA (2021) Imaging features of Susac syndrome on high-resolution intracranial vessel wall MRI. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000994","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11891_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jns.2010.08.028","volume":"299","author":"I Kleffner","year":"2010","unstructured":"Kleffner I, Deppe M, Mohammadi S et al (2010) Neuroimaging in Susac\u2019s syndrome: focus on DTI. J Neurol Sci 299:92\u201396. https:\/\/doi.org\/10.1016\/j.jns.2010.08.028","journal-title":"J Neurol Sci"},{"key":"11891_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000362868","volume":"6","author":"A Feresiadou","year":"2014","unstructured":"Feresiadou A, Eriksson U, Larsen H-C et al (2014) Recurrence of Susac syndrome following 23 years of remission. Case Rep Neurol 6:171\u2013175. https:\/\/doi.org\/10.1159\/000362868","journal-title":"Case Rep Neurol"},{"key":"11891_CR40","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s00415-019-09664-8","volume":"267","author":"S Machado","year":"2020","unstructured":"Machado S, Jouvent E, Klein I et al (2020) Cognitive dysfunction and brain atrophy in Susac syndrome. J Neurol 267:994\u20131003. https:\/\/doi.org\/10.1007\/s00415-019-09664-8","journal-title":"J Neurol"},{"key":"11891_CR41","first-page":"382","volume":"25","author":"TH Do","year":"2004","unstructured":"Do TH, Fisch C, Evoy F (2004) Susac syndrome: report of four cases and review of the literature. AJNR Am J Neuroradiol 25:382\u2013388","journal-title":"AJNR Am J Neuroradiol"},{"key":"11891_CR42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jns.2010.11.016","volume":"302","author":"TA Hardy","year":"2011","unstructured":"Hardy TA, Garsia RJ, Halmagyi GM et al (2011) Tumour necrosis factor (TNF) inhibitor therapy in Susac\u2019s syndrome. J Neurol Sci 302:126\u2013128. https:\/\/doi.org\/10.1016\/j.jns.2010.11.016","journal-title":"J Neurol Sci"},{"key":"11891_CR43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jns.2009.07.002","volume":"285","author":"S Jarius","year":"2009","unstructured":"Jarius S, Neumayer B, Wandinger KP et al (2009) Anti-endothelial serum antibodies in a patient with Susac\u2019s syndrome. J Neurol Sci 285:259\u2013261. https:\/\/doi.org\/10.1016\/j.jns.2009.07.002","journal-title":"J Neurol Sci"},{"key":"11891_CR44","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000151","volume":"2","author":"L Zhovtis Ryerson","year":"2015","unstructured":"Zhovtis Ryerson L, Kister I, Snuderl M et al (2015) Incomplete Susac syndrome exacerbated after natalizumab. Neurol Neuroimmunol Neuroinflamm 2:e151. https:\/\/doi.org\/10.1212\/NXI.0000000000000151","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"11891_CR45","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1038\/s41467-019-13593-5","volume":"10","author":"CC Gross","year":"2019","unstructured":"Gross CC, Meyer C, Bhatia U, Yshii L, Kleffner I, Bauer J, Tr\u00f6scher AR, Schulte-Mecklenbeck A, Herich S, Schneider-Hohendorf T, Plate H, Kuhlmann T, Schwaninger M, Br\u00fcck W, Pawlitzki M, Laplaud DA, Loussouarn D, Parratt J, Barnett M, Buckland ME, Hardy TA, Reddel SW, Ringelstein M, D\u00f6rr J, Wildemann B, Kraemer M, Lassmann H, H\u00f6ftberger R, Beltr\u00e1n E, Dornmair K, Schwab N, Klotz L, Meuth SG, Martin-Blondel G, Wiendl H, Liblau R (2019) CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nat Commun 10(1):5779. https:\/\/doi.org\/10.1038\/s41467-019-13593-5","journal-title":"Nat Commun"},{"key":"11891_CR46","doi-asserted-by":"publisher","unstructured":"Mateen FJ, Zubkov AY, Muralidharan R, Fugate JE, Rodriguez FJ, Winters JL, Petty GW (2012) Susac syndrome: clinical characteristics and treatment in 29 new cases. Eur J Neurol 19(6):800\u2013811. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03627.x","DOI":"10.1111\/j.1468-1331.2011.03627.x"},{"key":"11891_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/s0953-6205(00)00070-4","volume":"11","author":"I Marie","year":"2000","unstructured":"Marie I, Guegan-Massardier E, Levesque H et al (2000) Susac\u2019s syndrome or retinocochleocerebral vasculopathy: a misdiagnosed and overlooked disorder. Eur J Intern Med 11:108\u2013111. https:\/\/doi.org\/10.1016\/s0953-6205(00)00070-4","journal-title":"Eur J Intern Med"},{"key":"11891_CR48","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.clinimag.2009.09.003","volume":"34","author":"AM Allmendinger","year":"2010","unstructured":"Allmendinger AM, Spektor V, Destian S (2010) CT and MR imaging of Susac syndrome in a young male presenting with acute disorientation. Clin Imaging 34:138\u2013142. https:\/\/doi.org\/10.1016\/j.clinimag.2009.09.003","journal-title":"Clin Imaging"},{"key":"11891_CR49","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1007\/s00415-020-10086-0","volume":"267","author":"TA Hardy","year":"2020","unstructured":"Hardy TA, Taylor RL, Qiu J et al (2020) The neuro-otology of Susac syndrome. J Neurol 267:3711\u20133722. https:\/\/doi.org\/10.1007\/s00415-020-10086-0","journal-title":"J Neurol"},{"key":"11891_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.wjorl.2020.10.004","volume":"7","author":"PL P\u00e9rez","year":"2021","unstructured":"P\u00e9rez PL, McCall AA, Hirsch BE (2021) Scoping review of cochlear implantation in Susac\u2019s syndrome. World J Otorhinolaryngol Head Neck Surg 7:126\u2013132. https:\/\/doi.org\/10.1016\/j.wjorl.2020.10.004","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"11891_CR51","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3109\/08820538.2015.1122068","volume":"32","author":"K Kumar","year":"2017","unstructured":"Kumar K, Jariwala B, Raj P, Agarwal A (2017) Retinal neovascularisation in Susac syndrome: a rare complication. Semin Ophthalmol 32:492\u2013495. https:\/\/doi.org\/10.3109\/08820538.2015.1122068","journal-title":"Semin Ophthalmol"},{"key":"11891_CR52","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1177\/1120672120965482","volume":"31","author":"C Alba-Linero","year":"2021","unstructured":"Alba-Linero C, Liscombe-Sep\u00falveda JP, Lloren\u00e7 V et al (2021) Use of ultra-wide field retinal imaging and optical coherence tomography angiography in the diagnosis of incomplete Susac syndrome. Eur J Ophthalmol 31:3238\u20133247. https:\/\/doi.org\/10.1177\/1120672120965482","journal-title":"Eur J Ophthalmol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11891-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11891-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11891-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T02:02:44Z","timestamp":1699495364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11891-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["11891"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11891-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prof Jacob has served as an international advisory board member for Alexion, Alnylam, ArgenX, Immunovant, Janssen, Regeneron and UCB pharmaceuticals, is currently an expert panel member of Myasthenia Gravis consortium for Argenx pharmaceuticals, and has received speaker fees from Terumo BCT and Eisai pharmaceuticals. None of these are relevant to the submitted manuscript. Prof. Mollan reports advisory board membership for Invex Therapeutics and Janssen. She is currently a consultant for Neurodiem and has received speaker fees from Heidelberg Engineering, and Chugai-Roche Ltd. All outside the submitted work. Dr Appleton is supported in part by a National Institute of Health Research (NIHR) Health and Care Research Scholarship.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}